Multicenter phase II trial to evaluate the efficacy of Abound (nutrition product including HMB, arginine, and glutamine) on the clinical course of anastomotic leakage after gastrectomy in patients with gastric cancer
Phase 2
- Conditions
- Anastomotic leakage after gastrectomy for gastric cancer
- Registration Number
- JPRN-UMIN000028945
- Lead Sponsor
- agoya University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1) Severe pneumonia and sepsis 2) Leakage at the closed stump of duodenum and jejunum 3) Repeated surgery 4) Patients requiring a limiting of the water amount 5) Patients who underwent preoperative chemotherapy 6) Patients incompatible to Abound 7) Pregnancy 8) Ineligible for the study at the physician's assessment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The period from the diagnosis to cure of the anastomotic leakage
- Secondary Outcome Measures
Name Time Method Total amount and safety of Abound administration, duration of drain placement and fasting, hospital stay, location and procedure of anastomosis, blood test and nutritional management